Zobrazeno 1 - 10
of 300
pro vyhledávání: '"K. von Smitten"'
Publikováno v:
Annals of Surgical Oncology. 17:1669-1674
To investigate whether skin-sparing mastectomy (SSM) and immediate breast reconstruction (IBR) is a possible treatment option in selected cases of locally recurrent breast cancer after previous breast-conserving therapy (BCT).Sixty consecutive patien
Publikováno v:
Journal of Surgical Oncology. 98:21-26
Background Our aim was to investigate the prevalence of and risk factors for having four or more positive axillary lymph nodes among breast cancer patients undergoing sentinel node (SN) biopsy. Patients and Methods Between February 2005 and July 2007
Autor:
Päivi Heikkilä, K. von Smitten, Catarina Svarvar, Tuomo J. Meretoja, Tiina Jahkola, Marjut Leidenius
Publikováno v:
European Journal of Surgical Oncology (EJSO). 33:1142-1145
Aims Since the introduction of skin-sparing mastectomy (SSM) in 1991 concerns on local control and recurrence rates have been discussed in the literature. The aim of this study is to examine in particular incidence of local recurrence in a 15-year co
VEGF-D in Association With VEGFR-3 Promotes Nodal Metastasis in Human Invasive Lobular Breast Cancer
Publikováno v:
American Journal of Clinical Pathology. 128:759-766
We assessed the expression of vascular endothelial growth factors (VEGF-C and VEGF-D) in breast cancer cells and the density of lymph vessels and VEGF receptor-3 (VEGFR-3)–positive vessels in and around the tumor in invasive lobular breast cancer.
Autor:
S Rasia, Tuomo J. Meretoja, K. von Smitten, Tiina Jahkola, Hannu Kuokkanen, Sirpa Asko-Seljavaara
Publikováno v:
University of Helsinki
Background Skin-sparing mastectomy (SSM) facilitates optimal immediate breast reconstruction (IBR) by preserving the inframammary fold and most of the breast skin. Concerns persist that SSM might increase the rate of local recurrence as the surgical
Publikováno v:
European Journal of Surgical Oncology (EJSO). 32:488-491
Aims We aimed to evaluate the prevalence of and the risk factors for axillary lymph-node metastases in pure tubular carcinoma (PTC) of the breast. The role of axillary staging and treatment in PTC was also evaluated. Methods Between March 2001 and Au
Publikováno v:
Journal of Surgical Oncology. 94:380-384
Background Our aim was to evaluate the prevalence of and risk factors for tumour-positive sentinel node (SN) findings in patients with ductal carcinoma in situ (DCIS). Methods Altogether 1,470 patients underwent sentinel node biopsy (SNB) between Apr
Publikováno v:
European Journal of Surgical Oncology (EJSO). 31:364-368
Summary Aims We aimed to evaluate the outcome of sentinel node biopsy (SNB) in breast cancer patients with large primary tumours. Methods Nine hundred and eighty-four patients with invasive breast cancer and SNB were studied. The histological tumour
Publikováno v:
The Breast. 14:28-36
Posttreatment morbidity within 1 year after sentinel node biopsy was evaluated objectively by physical examination and also by evaluating patients self-reports of symptoms in a questionnaire. These patients were compared with patients who underwent a
Publikováno v:
Journal of Surgical Oncology. 92:23-31
Background The aim was to evaluate long-time morbidity in breast cancer patients 3 years after sentinel node biopsy (SNB) or axillary clearance (AC) emphasizing the consequences of morbidity like work-related events and the need of physiotherapy. Pat